Taken together, those data [122,137,140,194,195,196,197,198,199,200] indicate a real possibility of the usage of GRP78 gene-silencing vectors against breast cancer, and as such an approach enables to sensitization of this malignancy to chemotherapy, antiestrogen therapy and radiotherapy. Here, HSPA5 is linked to breast cancer.